Paper Review Records
All Paper Review Records
29 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Emilie A. Jochumsen; Jansen R. Seheult; Samantha Ngamsuntikul; Audra Taylor; Ulrik Sprogøe; Casey Vieni; Mark H. YazerShow moreShow less
1. Department of Clinical Immunology Odense University Hospital Odense Denmark; 2. Division of Hematopathology Mayo Clinic Rochester Minnesota USA; 3. South Texas Blood & Tissue San Antonio Texas USA; 4. Department of Pathology University of Utah Salt Lake City Utah USA; 5. Department of Pathology University of Pittsburgh Pittsburgh Pennsylvania USAShow moreShow less
Convalescent blood in Ebola: From a survivor's gift to a biologically defined therapeutic product
Serge Tonen‐Wolyec; John Katabuka‐Kalongo; Raelle Atenyi‐Kasemire; Salomon Batina‐Agasa; Laurent BélecShow moreShow less
1. Faculty of Medicine University of Bunia Bunia Democratic Republic of the Congo; 2. Service de la Polyclinique Citadelle Centre Interdisciplinaire de Recherche Translationnelle en Médecine et Sciences de la Santé Bunia Democratic Republic of the Congo; 3. Patient Care Department Ministry of Public Health Kinshasa Democratic Republic of the Congo; 4. Faculty of Medicine University of Kisangani Kisangani Democratic Republic of the Congo; 5. Faculty of Medicine University Paris Cité Paris France; 6. Service de Microbiologie Assistance Publique‐Hôpitaux de Paris (AP‐HP) Paris FranceShow moreShow less
Evaluation of rare and novel splicing variants in the RH system
Aline Floch; Sunitha Vege; Isabelle Gourlaouen; June Fuertes; Christine Lomas‐Francis; Yann Fichou; Connie M. WesthoffShow moreShow less
1. Immunohematology and Genomics Laboratory New York Blood Center Rye New York USA; 2. Univ Paris Est Creteil INSERM U955 Equipe « Transfusion et maladies du globule rouge », IMRB Créteil France; 3. Laboratoire de biologie médicale en immunohématologie moléculaire Etablissement francais du sang Ile‐de‐France Créteil France; 4. Inserm, EFS Univ Brest, UMR1078, GGB, Equipe Biomedicine and Integrative Genetics and Genomics (BIGG) Brest FranceShow moreShow less
Recipient and donor contact following unrelated allogeneic hematopoietic cell transplantation: The Canadian Blood Services' stem cell registry experience
An Duong; Olivia Norman; Nora Stevens; Patti Wright; Debra Bastien; Matthew D. Seftel; David S. AllanShow moreShow less
1. Ottawa Hospital Research Institute Ottawa Ontario Canada; 2. Stem Cells Canadian Blood Services Ottawa Ontario Canada; 3. Department of Medicine University of British Columbia Vancouver British Columbia Canada; 4. Department of Medicine University of Ottawa Ottawa Ontario CanadaShow moreShow less
Novel fluorescent interference preventing peripheral CD34 + cell enumeration in a healthy, mobilized hematopoietic progenitor cell apheresis donor
Scott Potter; Amy Rawson; Moriah Ludwig; Raphael A. Lizcano; Zbigniew M. Szczepiorkowski; Kenneth R. Meehan; Richard M. KaufmanShow moreShow less
1. Department of Pathology and Laboratory Medicine Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA; 2. Blood Donor Program Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA; 3. Geisel School of Medicine at Dartmouth Hanover New Hampshire USA; 4. Department of Hematology Dartmouth Hitchcock Medical Center Lebanon New Hampshire USAShow moreShow less
Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient‐derived anti‐E and anti‐K alloantibodies in vitro
Yaima Tundidor Cabado; Lazaro Gil Gonzalez; Yeniley Ruiz Noa; Alequis Pavon Oro; Akash Gupta; Yulia Lin; Heather VanderMeulen; Noah Zweig; Harley Meirovich; Amie Malkin; Chantal Armali; Katrina Billingsley; Donald R. Branch; Alan H. LazarusShow moreShow less
1. Innovation Canadian Blood Services Ottawa Ontario Canada; 2. Keenan Research Centre for Biomedical Science St. Michael's Hospital Toronto Canada; 3. Department of Medicine and Laboratory Medicine and Pathobiology University of Toronto Toronto Canada; 4. Medical Affairs Division Canadian Blood Services Ottawa Ontario Canada; 5. Precision Diagnostics and Therapeutics Program Sunnybrook Health Sciences Centre Toronto Ontario Canada; 6. LifeShare Shreveport Louisiana USAShow moreShow less
FAQ
How long does TRANSFUSION take to review a manuscript?
As of 2026-11-17, CrushSCI has 29 complete review records for TRANSFUSION. The fastest paper went from submission to acceptance in 1 days (Convalescent blood in Ebola: From a survivor's gift to a biologically defined therapeutic product, received 2026-11-03, accepted 2026-11-04); the slowest took 231 days. The average is 86.1 days and the median is 80 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
